Document 0618 DOCN M9550618 TI Laboratory study of HIV-1 and HTLV-I/II coinfection. DT 9505 AU Beilke MA; Greenspan DL; Impey A; Thompson J; Didier PJ; Section of Infectious Diseases, Tulane University School of; Medicine, New Orleans, LA 70112. SO J Med Virol. 1994 Oct;44(2):132-43. Unique Identifier : AIDSLINE MED/95156017 AB A Retroviral Coinfection Clinic was established in 1991 at Charity Hospital Medical Center of Louisiana to study patients dually infected with human immunodeficiency virus (HIV) and human T lymphotropic virus (HTLV-I, HTLV-II). Eight patients were evaluated clinically, and by immunological and virological studies. Multiple neuromuscular diseases were observed, including tropical spastic paraparesis, polymyositis, and polyneuropathies. Only one patient developed AIDS. HIV-1 infected patients with HTLV-I, but not HTLV-II, coinfection have maintained stable CD4 counts, despite the fact that quantitative HIV DNA PCR suggests a relatively high copy number. HTLV-I/II antigens were detected in lymphocyte cultures from four patients, and lymphoblastoid cell lines have been established from two. These results support the contention that upregulated HTLV-I/II virus expression and disease manifestations occur during coinfection with HIV, sometimes in association with normal CD4 counts. DE Adult Cell Line, Transformed CD4 Lymphocyte Count DNA, Viral/GENETICS/ISOLATION & PURIF Female Human HIV Infections/*COMPLICATIONS/IMMUNOLOGY/VIROLOGY *HIV-1/GENETICS HTLV-I/GENETICS/ISOLATION & PURIF HTLV-I Infections/*COMPLICATIONS/IMMUNOLOGY/VIROLOGY HTLV-II/GENETICS/ISOLATION & PURIF HTLV-II Infections/*COMPLICATIONS/IMMUNOLOGY/VIROLOGY Male Middle Age Polymerase Chain Reaction Prognosis Prospective Studies Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. CLINICAL TRIAL JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).